Clinical Updates & Insights

Share

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

202 Clinical Updates found
Clinical Update
Colorectal Liver
Hepatic Arterial Infusion Converts “Unresectable” Colorectal Liver Mets
The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.
Clinical Update
Nai-Kong Cheung, MD, PhD
New Molecular Signatures of High-Risk Neuroblastoma
High-risk neuroblastoma cells harbor distinguishing molecular signatures, according to recent research.
Clinical Update
oligodendroglioma
Chemotherapy Reduces Seizures in Low-Grade Oligodendroglioma
Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.
Clinical Update
Dr. Anthony F. Yu and patient
Minimizing Cardiotoxicities of Contemporary Breast Cancer Treatments
In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.
Clinical Update
radiation therapy
Nasal Cavity Cancer: Radiation Is a Valid Option for Patients Refusing Surgery
Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.
Clinical Update
surgeons operating on patient
Tackling Lymphedema: New Insights from MSK’s Dedicated Lab
New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.
Clinical Update
Radiation Oncologist,  Suzanne Wolden with child patient
Less Is Better: Promising Results for Reduced-Dose Radiation Therapy in High-Risk Pediatric Neuroblastoma
Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.
Clinical Update
Intensity-modulated radiation therapy (IMRT)
Less Risk of Femoral Fracture with Intensity-Modulated Radiation Therapy for Thigh and Groin Sarcoma
Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.
Clinical Update
Doctors looking at x-ray
Surgery Is Critical in Advanced Testicular Cancer
Resection of all residual disease after salvage chemotherapy offers the best chance for a cure for patients with refractory or relapsed advanced testicular cancer, according to the results of our recent retrospective study.
Clinical Update
Robert Young
Deep Learning with MRI-Radiomics Improves Survival Prediction in Glioblastoma
Incorporating radiomics with methyl guanine methyl transferase (MGMT) status can more accurately stratify glioblastoma patients into groups with different survival risks compared to using either prediction tool in isolation.